With the incidence of type 2 diabetes increasing at alarming rates, fortunately there has also been a dramatic increase in advanced treatment options for the disease. We have gone from just two treatment class options in 1995 to currently more than ten treatment class options—with several more advancements being researched.
Currently, two classes of medication are being prescribed more often to treat type 2 diabetes: injectable incretin agents and oral incretin agents. These medications help the pancreas produce more insulin. These treatments, especially the injectable agents, promote significant weight loss, maintain better blood sugar levels and restore quality of life for type 2 diabetic patients.
Properly treating and managing the disease is extremely important to reduce risk of other serious health conditions such as heart disease, stroke, kidney disease, eye and nerve damage. Therefore it is important to remember that medication management is just one factor in treating type 2 diabetes. Controlling blood pressure, reducing cholesterol and triglycerides, stopping smoking, maintaining a proper diet, and exercise are all crucial to the success of type 2 diabetes medications.
Fortunately, Cone Health has an exceptional network of primary care physicians, endocrinologists, dieticians and other related medical professionals dedicated to educating the community about type 2 diabetes and providing individualized treatment to improve the health and quality of life of their patients.
Dr. Michael Brennan is a pediatric endocrinologist at Cone Health Pediatric Sub-Specialists of Greensboro. He also specializes in adult endocrinology. Dr. Brennan is a 1978 medical school graduate of University of Massachusetts. He completed his residency in Internal Medicine and Pediatrics and a fellowship in Adult and Pediatric Endocrinology and Metabolism at Walter Reed Army Medical Center.